| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | M Camilleri | |
| J E Kellow | |||
| M Delvaux | |||
| F Azpiroz | |||
| E M Quigley | |||
| D G Thompson | |||
| P2860 | cites work | Altered pain perception and psychosocial features among women with gastrointestinal disorders and history of abuse: A preliminary model | Q60701436 |
| Patients with irritable bowel syndrome have greater pain tolerance than normal subjects | Q69215043 | ||
| Therapy of irritable bowel syndrome--an overview | Q70869305 | ||
| Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities | Q72330659 | ||
| Site of pain from the irritable bowel | Q72430612 | ||
| Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome | Q72568232 | ||
| Selective dysfunction of mechanosensitive intestinal afferents in irritable bowel syndrome | Q72590053 | ||
| Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. The Working Team of Glaxo-Wellcome Research, UK | Q73114650 | ||
| Helicobacter pylori infection and gastric emptying of indigestible solids in patients with dysmotility-like dyspepsia | Q73563653 | ||
| Intestinal gas dynamics and tolerance in humans | Q77164856 | ||
| Role of impaired gastric accommodation to a meal in functional dyspepsia | Q77620673 | ||
| The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome | Q77738375 | ||
| Brain-gut axis in health and disease | Q32100234 | ||
| Scintigraphic measurement of gastric emptying and ultrasonographic assessment of antral area: relation to appetite | Q34409756 | ||
| Plasma nitrate concentration in infective gastroenteritis and inflammatory bowel disease | Q34410349 | ||
| Evaluation of colonic myoelectrical activity in health and functional disorders | Q34494984 | ||
| Origin of chronic right upper quadrant pain | Q34527052 | ||
| Dysmotility of the small intestine in irritable bowel syndrome | Q34532696 | ||
| Functional abdominal pain: further evidence that whole gut is affected. | Q34760485 | ||
| Ambulatory gastrojejunal manometry in severe motility-like dyspepsia: lack of correlation between dysmotility, symptoms, and gastric emptying. | Q35349445 | ||
| Evidence for a lipid specific effect in nutrient induced human proximal gastric relaxation | Q35351790 | ||
| Physiology and pathophysiology of colonic motor activity (1). | Q36495464 | ||
| Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception | Q38549269 | ||
| Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders | Q40387175 | ||
| Basic and clinical aspects of visceral hyperalgesia | Q40666271 | ||
| Octreotide in gastrointestinal motility disorders | Q40764379 | ||
| Erythromycin and other macrolides as prokinetic agents | Q40786851 | ||
| Loperamide. Survey of studies on mechanism of its antidiarrheal activity | Q40915499 | ||
| Functional dyspepsia. Insights on mechanisms and management strategies | Q41017340 | ||
| Gastric and small intestinal motility in health and disease | Q41017350 | ||
| Therapeutic strategies for motility disorders. Medications, nutrition, biofeedback, and hypnotherapy | Q41017399 | ||
| Drugs affecting serotonin receptors | Q41032429 | ||
| Tolerance for rectosigmoid distention in irritable bowel syndrome | Q41227327 | ||
| The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders | Q41243141 | ||
| Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations | Q41459573 | ||
| Irritable bowel syndrome: a technical review for practice guideline development | Q41493711 | ||
| Twenty four hour manometric recording of colonic motor activity in healthy man. | Q42121509 | ||
| Neurohormonal factors in functional dyspepsia: insights on pathophysiological mechanisms | Q44708051 | ||
| Variation of muscle tone in the human colon | Q45024896 | ||
| Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia | Q46284007 | ||
| The origin of symptoms on the brain-gut axis in functional dyspepsia | Q48644078 | ||
| Regional cerebral activity in normal and pathological perception of visceral pain | Q48824919 | ||
| Effects of different types of stress and of "prokinetic" drugs on the control of the fasting motor complex in humans. | Q49011614 | ||
| Diurnal changes in myoelectric spiking activity of the human colon | Q49043050 | ||
| Association between H. pylori, duodenal mechanosensory thresholds, and small intestinal motility in chronic unexplained dyspepsia. | Q51025368 | ||
| Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. | Q51035370 | ||
| Jejunal sensorimotor dysfunction in irritable bowel syndrome: clinical and psychosocial features. | Q51116970 | ||
| Antidepressants for functional gastrointestinal syndromes. | Q52022100 | ||
| Measurement of gastrointestinal motility in the GI laboratory. | Q53946989 | ||
| Selective gastric hypersensitivity and reflex hyporeactivity in functional dyspepsia | Q57241225 | ||
| A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin | Q60632645 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | physiology | Q521 |
| P304 | page(s) | II17-24 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | Principles of applied neurogastroenterology: physiology/motility-sensation | |
| P478 | volume | 45 Suppl 2 |
| Q35219100 | Acalculous biliary pain: new concepts for an old entity |
| Q37104716 | Bladder and bowel dysfunction in Parkinson's disease |
| Q35209869 | Bladder, bowel, and sexual dysfunction in Parkinson's disease |
| Q34542743 | Chewing gum for enhancing early recovery of bowel function after caesarean section |
| Q43312754 | Chronic visceral hypersensitivity renders defecation more susceptible to stress via a serotonergic pathway in rats |
| Q35596065 | Cluster analysis of symptoms and health seeking behaviour differentiates subgroups of patients with severe irritable bowel syndrome |
| Q37731809 | Enhancing the placebo response: functional magnetic resonance imaging evidence of memory and semantic processing in placebo analgesia |
| Q36485768 | Experimental human pain models in gastro-esophageal reflux disease and unexplained chest pain |
| Q37215520 | Factors influencing functional abdominal pain in children |
| Q37216902 | Functional connectivity of the default mode network and its association with pain networks in irritable bowel patients assessed via lidocaine treatment |
| Q37398431 | Gastric stasis in migraineurs: etiology, characteristics, and clinical and therapeutic implications |
| Q33433539 | Intestinal gas dynamics: mechanisms and clinical relevance |
| Q39344006 | Low-dose naltreoxone for the treatment of irritable bowel syndrome: a pilot study |
| Q33893275 | Mebeverine for pediatric functional abdominal pain: a randomized, placebo-controlled trial. |
| Q39308242 | Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation |
| Q34479610 | Pathophysiology and management of irritable bowel syndrome |
| Q33787841 | Proximal gastric motility in critically ill patients with type 2 diabetes mellitus |
| Q33867555 | Proximal gastric response to small intestinal nutrients is abnormal in mechanically ventilated critically ill patients |
| Q74256178 | Psychologic Therapies for Irritable Bowel Syndrome |
| Q35597727 | Rectal sensorimotor dysfunction in patients with urge faecal incontinence: evidence from prolonged manometric studies |
| Q44410775 | Regulatory role of 5-HT and muscarinic receptor antagonists on the migrating myoelectric complex in rats. |
| Q34699839 | Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome |
| Q38358025 | Software for enhanced video capsule endoscopy: challenges for essential progress |
| Q37263978 | Sphincter EMG as a diagnostic tool in autonomic disorders |
| Q34852895 | Synbiotic containing Bacillus coagulans and fructo-oligosaccharides for functional abdominal pain in children |
| Q80311612 | [Are the definitions of functional digestive disorders based on the Rome criteria useful in clinical practice?] |
Search more.